Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nicholas Simon


  • Large Shareholder, Director at Gritstone Oncology Inc. (GRTS), 2019-06-20
  • Director at Sientra Inc. (SIEN), 2019-06-18
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Forty Seven Inc. (FTSV), 2018-07-02
  • Large Shareholder at Restoration Robotics Inc (HAIR), 2017-10-17
  • Large Shareholder at Tetralogic Pharmaceuticals Corp (TLOG), 2016-02-10
  • Large Shareholder at Oxford Immunotec Global Plc (OXFD), 2015-06-17
  • Large Shareholder at Ophthotech Corp. (OPHT), 2015-05-28
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2015-01-30
  • Other at Globus Medical Inc (GMED), 2013-09-04
  • Director at Achillion Pharmaceuticals Inc (ACHN), 2012-06-06
  • Large Shareholder at Zogenix Inc. (ZGNX), 2011-09-20
  • Large Shareholder at Avanir Pharmaceuticals Inc. (AVNR), 2010-12-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GRTS $15.00 333,333 Large Shareholder, Director 333,333 2018-09-28 Filing